Northern Trust Corp Has $110.83 Million Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Northern Trust Corp boosted its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 11.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,155,043 shares of the company's stock after purchasing an additional 121,001 shares during the period. Northern Trust Corp owned about 1.33% of HealthEquity worth $110,826,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Wealthfront Advisers LLC acquired a new stake in HealthEquity during the 4th quarter worth about $10,304,089,000. Vanguard Group Inc. grew its stake in HealthEquity by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company's stock worth $861,256,000 after purchasing an additional 99,624 shares during the period. FMR LLC increased its holdings in HealthEquity by 2.4% in the fourth quarter. FMR LLC now owns 5,415,800 shares of the company's stock worth $519,646,000 after purchasing an additional 125,684 shares in the last quarter. Geode Capital Management LLC lifted its stake in HealthEquity by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 2,089,398 shares of the company's stock valued at $200,522,000 after buying an additional 10,421 shares during the period. Finally, Franklin Resources Inc. boosted its holdings in shares of HealthEquity by 0.7% during the 3rd quarter. Franklin Resources Inc. now owns 1,640,215 shares of the company's stock worth $139,369,000 after buying an additional 11,659 shares in the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now directly owns 78,219 shares of the company's stock, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Michael Henry Fiore sold 8,881 shares of the firm's stock in a transaction dated Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the sale, the executive vice president now owns 56,655 shares of the company's stock, valued at $4,433,820.30. This trade represents a 13.55 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 20,381 shares of company stock valued at $1,781,432. Corporate insiders own 2.20% of the company's stock.

HealthEquity Stock Performance

NASDAQ HQY opened at $90.58 on Friday. The company has a fifty day moving average price of $89.55 and a 200-day moving average price of $96.57. The firm has a market cap of $7.83 billion, a price-to-earnings ratio of 83.10, a PEG ratio of 1.60 and a beta of 0.49. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59.

Analysts Set New Price Targets

A number of research analysts recently issued reports on HQY shares. Barrington Research reiterated an "outperform" rating and set a $112.00 target price on shares of HealthEquity in a research report on Friday, April 11th. The Goldman Sachs Group cut their price objective on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a research report on Thursday, March 27th. Raymond James raised HealthEquity from an "outperform" rating to a "strong-buy" rating and decreased their target price for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. Wells Fargo & Company increased their price target on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. Finally, KeyCorp decreased their price objective on HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. One analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $111.75.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.